Clinical assessment of squamous cell carcinoma of the nasal cavity proper.
The subjects were 14 patients with squamous cell carcinoma or undifferentiated carcinoma of the nasal cavity treated at Nihon University Hospital between October 1984 and November 1991, who were followed for at least 3 years. The site of the tumor origin within the nasal cavity was the lateral wall in 8 patients, the nasal septum in three patients, and unknown in three patients. Histologically, there were 13 squamous cell carcinomas in (3 well differentiated, 7 moderately differentiated, and 3 poorly differentiated) and 1 undifferentiated carcinoma. Treatment was by a combination of radiotherapy, chemotherapy, and surgery in 8 cases, a combination of radiotherapy and surgery in 5 cases, and surgery alone in 1 case. The 3-year and 5-year Kaplan-Meier survival rates were 86 and 69%, respectively. A total of 6 patients suffered a recurrence, with local recurrence occurring in 4 patients and pulmonary metastasis in 2 patients. Tumor control was achieved in 3 of the 4 cases of local recurrence by reoperation, and by surgery in 1 of the 2 cases of pulmonary metastasis. The duration of the recurrence-free interval in the patients who developed local recurrences, 18 to 46 months after the completion of the initial course of therapy, was of considerable interest.
Kida
A
A
Department of Otorhinolaryngology, Nihon University Surugadai Hospital, Tokyo, Japan.
Endo
S
S
Iida
H
H
Yamada
Y
Y
Sakai
F
F
Furusaka
T
T
Ishiyama
K
K
D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000473:pathology* / Q000601:surgery; D005260:Female; D006801:Humans; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009300:Nasal Septum / Q000473:pathology* / Q000601:surgery; D009305:Nasopharynx / Q000473:pathology* / Q000601:surgery; D009362:Neoplasm Metastasis; D010255:Paranasal Sinus Neoplasms / Q000175:diagnosis* / Q000473:pathology* / Q000601:surgery; D012008:Recurrence; D012720:Severity of Illness Index; D015996:Survival Rate